Improving the effectiveness of existing chemotherapy
Pleco Therapeutics Announces Final Close of its Series A Financing Raising €17.3m
15-Sep-2022 -
Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer micro-environment announces the final close of its Series A financing, with total funds raised of €17.3 million. The funds will be used to complete development and ...
acute myeloid leukemia
cancer
chemotherapy
+1